Home Your basket
• An important procedure in...
   Price 8.50 €
• Functional septal surgery...
   Price 10.50 €
• Metastatic melanoma to th...
   Price 5.50 €
• A survey of current wound...
   Price 5.50 €
• The “Deglutition Handicap...
   Price 10.50 €
• Oto-rhino-laryngology and...
   Price 10.50 €
• Early evaluation of voice...
   Price 12.00 €
• Laryngeal neuroendocrin c...
   Price 5.50 €
• Planned reconstruction af...
   Price 8.50 €
• What is the effect of diz...
   Price 10.50 €
• Fistula of the fourth bra...
   Price 5.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Cottle's technique septop...
   Price 5.50 €
• A simple assessment of qu...
   Price 10.50 €
• Recurrent ameloblastoma o...
   Price 8.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Persistent stapedial arte...
   Price 5.50 €
• Importance of a molding n...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Acoustic analysis of the ...
   Price 10.50 €
• Oculo-orbital complicatio...
   Price 14.00 €
• Supra and infra hyoid mid...
   Price 10.50 €
• A rare tumor of the parap...
   Price 5.50 €
• Influence of phonetic con...
   Price 10.50 €
• Quality of life after oro...
   Price 10.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Adenocarcinoma of the eth...
   Price 8.50 €
• High click stimulus repet...
   Price 10.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• A new case of rhinosclero...
   Price 5.50 €
• Eagle syndrom: A case rep...
   Price 8.50 €
• Exploration of the otolit...
   Price 10.50 €
• Adenomatoid hamartoma of ...
   Price 5.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Isolated tracheo-œsophage...
   Price 5.50 €
• Contribution to anatomica...
   Price 10.50 €
• Implementation of the Eur...
   Price 10.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Bronchogenic cyst of the ...
   Price 10.50 €
• Laryngeal schwannoma: A c...
   Price 5.50 €
• Cochlear implantation in ...
   Price 12.50 €
• Side-to-end hypoglossal-f...
   Price 10.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Evaluation of a dysphonic...
   Price 10.50 €
• Oncocytoma of the parotid...
   Price 8.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Paranasal sinus mucoceles...
   Price 14.00 €
• Thyroid surgery (356 case...
   Price 10.50 €
• Hearing evaluation on you...
   Price 8.50 €
• Extraction of the esophag...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Teeth and sinuses...
   Price 8.50 €
• Esthesioneuroblastoma....
   Price 5.50 €
• Overlay versus underlay t...
   Price 10.50 €
• Oropharyngeal reconstruct...
   Price 10.50 €
• Proposal of a rating scal...
   Price 10.50 €
• Congenital bilateral choa...
   Price 5.50 €
• Functional anatomy of the...
   Price 14.00 €
• Post-traumatic carotid ca...
   Price 8.50 €
• Aspects of voice quality ...
   Price 5.50 €
• Sinonasal hemangiopericyt...
   Price 10.50 €
• Papillary thyroid carcino...
   Price 10.50 €
• A histopathologic evaluat...
   Price 8.50 €
• Life after total laryngec...
   Price 8.50 €
• From intelligibility to c...
   Price 10.50 €
• How I do it: Salivary duc...
   Price 8.50 €
• A protocol for post-opera...
   Price 5.50 €
• Epidermoid carcinoma of p...
   Price 10.50 €
• Pre-Congress of the Ameri...
   Price 8.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Chondrosarcoma of the hyo...
   Price 12.50 €

Total Order 648.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 4 - 2011 o

CANCER

Total pharyngolayngectomy in the 21st century: Indica­tions, oncologic and functional outcomes


Authors : Agopian B, Dassonville O, Chamorey E, Poissonnet G, Pierre S, Peyrade F, Hebert C, Benezery K, Viel D, Sudaka A, Vallicioni J, Demard F, Santini J, Bozec A. (Nice)

Ref. : Rev Laryngol Otol Rhinol. 2011;132,4:209-214.

Article published in french
Downloadable PDF document french



Summary : Introduction: The development of laryngeal preservation protocols has considerably modified the indications for total (pharyngo-)laryngectomy (TPL). The objectives of our study are to analyze the current indications for TPL and to evaluate the oncologic and functional outcomes after TPL and their predictive factors. Methods: All patients who underwent TPL for squamous cell carcinoma of the larynx or hypopharynx, at our institution, between 2000 and 2009, were included in this retrospective study. Predictive factors of oncologic and functio­nal outcomes were assessed in univariate and multivariate analyzes. Results: A total of 130 patients were enrolled in our study including 119 men and 11 women, with a mean age of 65.9 years. TPL was realized for salvage in 65 patients. Extra-laryngeal tumor extension (n= 42) was the main indication for TPL in the 65 remaining patients. Overall survival was 49 and 41% at 3 and 5 years respectively. In multivariate analysis, prima­ry tumor site (hypopharynx in comparison to larynx; p= 0.04) has a significant pejorative impact on overall survi­val. Oral alimentation (no enteral nutrition) was recovered successfully by 94% of the patients. In multivariate analysis, primary tumor site (hypopharynx) has a significant pejorative impact on functional results (deglutition: p< 0.0001; phona­tion: p= 0.03). Conclusion: Primary tumor site is one of the main predictive factor of oncologic and functional outcomes after TPL.


Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE